The present invention relates generally to novel therapeutic compounds and AXOR 109 agonists, and processes for the manufacture and use of the same.

 
Web www.patentalert.com

< AZACYCLYLISOQUINOLINONE AND ISOINDOLINONE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS

> 5-AMINOINDOLE DERIVATIVES AS H3 INVERSE AGONISTS

> Novel MAO-A inhibitors
~ 00503